Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hefei China Resources Sanjiu Pharmaceutical is a key subsidiary of China Resources Sanjiu Medical & Pharmaceutical Co., Ltd., one of China's leading state-owned pharmaceutical enterprises. Based in Hefei, the company specializes in the research, development, and large-scale manufacturing of over-the-counter (OTC) medicines and Traditional Chinese Medicine (TCM) products. It is a primary production base for the iconic "999" brand, which holds a dominant market share in China for respiratory and digestive health remedies. The company's portfolio includes a wide range of dosage forms such as granules, tablets, and capsules, supported by advanced TCM extraction technologies. As part of the broader China Resources Group, the company leverages an extensive national distribution network to maintain its position as a leader in the Chinese consumer healthcare sector.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hefei Huarun Sanjiu Pharmaceutical.